Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

201 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
False chloroquine resistance in Africa.
Basco LK, Ringwald P, Manéné AB, Chandenier J. Basco LK, et al. Lancet. 1997 Jul 19;350(9072):224. doi: 10.1016/S0140-6736(05)62397-5. Lancet. 1997. PMID: 9250219 No abstract available.
Assessment of three in vitro tests and an in vivo test for chloroquine resistance in Plasmodium falciparum clinical isolates.
Bickii J, Basco LK, Ringwald P. Bickii J, et al. J Clin Microbiol. 1998 Jan;36(1):243-7. doi: 10.1128/JCM.36.1.243-247.1998. J Clin Microbiol. 1998. PMID: 9431956 Free PMC article.
The 50% inhibitory concentrations determined by the two isotopic tests were similar and were highly correlated (r = 0.965; P < 0.05), showing a high concordance between the semimicrotest and the microtest. ...

The 50% inhibitory concentrations determined by the two isotopic tests were similar and were highly correlated (r = 0.965; P < 0.0

Monitoring of the therapeutic efficacy of chloroquine for the treatment of uncomplicated, Plasmodium falciparum malaria in Iran.
Raeisi A, Ringwald P, Safa O, Shahbazi A, Ranjbar M, Keshavarz H, Nateghpour M, Faraji L. Raeisi A, et al. Ann Trop Med Parasitol. 2006 Jan;100(1):11-6. doi: 10.1179/136485906X86220. Ann Trop Med Parasitol. 2006. PMID: 16417708
Given these observations, the replacement of chloroquine, as the first-line drug for the treatment of uncomplicated, P. falciparum malaria in Iran, was inevitable. ...
Given these observations, the replacement of chloroquine, as the first-line drug for the treatment of uncomplicated, P. falciparum ma …
Chloroquine self-treatment and clinical outcome of cerebral malaria in children.
Picot S, Nkwelle Akede A, Chaulet JF, Tetanye E, Ringwald P, Prévosto JM, Boudin C, Ambroise-Thomas P. Picot S, et al. Clin Exp Immunol. 1997 May;108(2):279-83. doi: 10.1046/j.1365-2249.1997.d01-996.x. Clin Exp Immunol. 1997. PMID: 9158098 Free PMC article.
[Surveillance of falciparum malaria susceptibility to antimalarial drugs and policy change in the Comoros].
Silai R, Moussa M, Abdalli Mari M, Astafieva-Djaza M, Hafidhou M, Oumadi A, Randrianarivelojosia M, Said Ankili A, Said Ahmed B, Gayibor AH, Ariey F, Ringwald P. Silai R, et al. Bull Soc Pathol Exot. 2007 Feb;100(1):6-9. doi: 10.3185/pathexo2898. Bull Soc Pathol Exot. 2007. PMID: 17402684 Clinical Trial. French.
Amodiaquine remains effective for treating uncomplicated malaria in west and central Africa.
Brasseur P, Guiguemde R, Diallo S, Guiyedi V, Kombila M, Ringwald P, Olliaro P. Brasseur P, et al. Trans R Soc Trop Med Hyg. 1999 Nov-Dec;93(6):645-50. doi: 10.1016/s0035-9203(99)90083-4. Trans R Soc Trop Med Hyg. 1999. PMID: 10717757 Clinical Trial.
Cardiac effects of amodiaquine and sulfadoxine-pyrimethamine in malaria-infected African patients.
Ngouesse B, Basco LK, Ringwald P, Keundjian A, Blackett KN. Ngouesse B, et al. Am J Trop Med Hyg. 2001 Dec;65(6):711-6. doi: 10.4269/ajtmh.2001.65.711. Am J Trop Med Hyg. 2001. PMID: 11791962 Clinical Trial.
Significantly prolonged P, PQ, QRS, and QTc intervals were recorded on Day 2 after both 30 and 35 mg of amodiaquine base per kilogram of body weight had been administered, but these intervals were not correlated with the plasma monodesethylamodiaquine (main human active me …
Significantly prolonged P, PQ, QRS, and QTc intervals were recorded on Day 2 after both 30 and 35 mg of amodiaquine base per kilogram …
201 results
Jump to page
Feedback